Paul C. Raymond, a director at Calumet, Inc. /DE (NASDAQ:CLMT), filed a Form 4 on August 21, 2026, reporting the acquisition of two tranches of Restricted Stock Units with a transaction date of August 20, 2026.

Key Highlights

  • Reporting person: Paul C. Raymond, identified as a Director of Calumet, Inc. /DE
  • First RSU grant: 534 Restricted Stock Units acquired at $0, reported as 100% vested, settleable upon the earlier of a date specified by the reporting person or termination
  • Second RSU grant: 178 Restricted Stock Units acquired at $0 under the Deferred Compensation Plan, vesting 25% on July 1 of each year beginning July 1, 2027
  • Underlying security: Each Restricted Stock Unit is the economic equivalent of one share of Common Stock, par value $0.01 per share
  • Beneficial ownership following transactions: 534 RSUs (first tranche) and 178 RSUs (second tranche), both held directly
  • Form signed: by Connor J. Egan as attorney-in-fact on August 21, 2026

Details of Paul C. Raymond's RSU Acquisitions at Calumet

According to the filing, Paul C. Raymond, a director at Calumet, Inc. /DE (NASDAQ:CLMT), reported two separate acquisitions of Restricted Stock Units (RSUs) in Table II of the Form 4, both dated August 20, 2026. The filing indicates no cash consideration was paid for either grant, with each RSU reported at a price of $0. The filing notes that "each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share."

The first tranche of 534 RSUs is described in the filing as "100% vested" and will be settled upon the earlier of a date specified by the reporting person or the reporting person's termination date. Following this transaction, Raymond directly holds 534 RSUs in this tranche. The second tranche of 178 RSUs was granted under the Deferred Compensation Plan and carries a vesting schedule: according to the filing, "25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027," with settlement triggered upon the earlier of a date specified by the reporting person or termination. Raymond directly holds 178 RSUs in this tranche following the transaction.

No transactions were reported in Table I, which covers non-derivative securities. The Form 4 was filed by one reporting person and was signed by Connor J. Egan as attorney-in-fact on August 21, 2026.

What Was Disclosed

Director Paul C. Raymond disclosed the acquisition of a total of 712 Restricted Stock Units in Calumet, Inc. /DE across two tranches on August 20, 2026, with differing vesting terms, both settled in Common Stock at $0.01 par value per share.